NIH Patents and Patent Applications

This list includes non-provisional and PCT patent filings.

CSV download of the complete patent data set.

For information on patent application codes, country codes, and patent status, see the Patents FAQ.

Tips:
Reset the Search Filters to go back to the initial display of all records.
Sort columns by clicking on the blue column headers.
The Search function searches across all columns.
To filter results by Lead IC, Country, or Application, type or use the dropdown menu.

Lead IC Reference Number Title Country Patent Application Type Application Number Date Filed Patent Number Date Issued Patent Status Patent PDF
NCI E-065-2013-0-US-01 FKBP52 Targeting Agent Pharmaceutical Compositions US 61/788,716 Abandoned
NHGRI E-243-2012-0-US-01 Synthetic Methylmalonyl-CoA Mutase Transgene For The Treatment Of Mut Class Methylmalonic Acidemia (MMA) US 61/792,081 Abandoned
NCATS E-046-2013-3-US-01 Process For Synthesis Of Enantioenriched Aminoalcohols Containing A Tertiary Alcohol Fragment, And Derivatives Of Those Aminoalcohols Including The Co-crystal Of VT-1129 With Benzenesulfonic Acid (BSA). US 61/801,784 Abandoned
NCATS E-083-2013-0-US-01 Measurement of Cellular FMRP Levels for High Throughput Drug Screening and Diagnosis of Fragile X Syndrome US 61/793,577 Abandoned
NCI E-033-2013-0-US-01 Stabilized Single Human CD4 Domains And Fusion Proteins US 61/791,885 Abandoned
NIAID E-081-2013-1-US-01 PREFUSION RSV F PROTEINS AND THEIR USE US 61/798,389 Abandoned
NIA E-139-2012-1-US-01 Methods of Regulating Cannabinoid Receptor Activity-Related Disorders and Diseases US 61/789,629 Abandoned
NCATS E-023-2013-0-US-01 NRF2 SMALL MOLECULE INHIBITORS FOR CANCER THERAPY US 61/798,843 Abandoned
NCI E-035-2013-0-US-01 Inhibitors Of The Linear Ubiquitin Chain Assembly Complex (LUBAC) and Related Methods US 61/789,064 Abandoned
NIDA E-086-2013-0-US-01 High-Affinity Dopamine D3 Receptor Antagonists And Partial Agonist US 61/788,167 Abandoned
NCATS E-046-2013-0-US-01 Process For Synthesis Of Enantioenriched Aminoalcohols Containing A Tertiary Alcohol Fragment, And Derivatives Of Those Aminoalcohols Including The Co-crystal Of VT-1129 With Benzenesulfonic Acid (BSA). US 61/802,071 Abandoned
NCATS E-046-2013-1-US-01 Process For Synthesis Of Enantioenriched Aminoalcohols Containing A Tertiary Alcohol Fragment, And Derivatives Of Those Aminoalcohols Including The Co-crystal Of VT-1129 With Benzenesulfonic Acid (BSA). US 61/802,217 Abandoned
NIAID E-080-2013-1-US-01 Attenuation of Human Respiratory Syncytial Virus By Genome Scale Codon-Pair Deoptimization US 61/794,155 Abandoned
NCATS E-144-2012-2-CA-03 SALICYLIC ACID DERIVATIVES USEFUL AS GLUCOCEREBROSIDASE ACTIVATORS CA National Stage 2868484 Abandoned
NIAID E-117-2013-0-CN-01 ANTI-RSV HIGH NEURTRALIZATION ANTIBODY AND THE PEPTIDE CAN BE USED FOR PREVENTION OF RSV INFECTION AND RELATED DISEASE CN ORD 201310082338.1 Abandoned
NCI E-056-2012-0-PCT-02 ZIRCONIUM-89 COMPLEXES, METHODS OF LABELING CELLS, LABELED CELLS, KITS, AND METHODS OF USE THEREOF PCT PCT PCT/US1331944 Expired
NCI E-217-2011-1-CA-05 Novel Interferon-Lambda4 (IFNL4) Protein, Related Nucleic Acid Molecules, and Uses Thereof CA National Stage 2869899 Issued
NCI E-217-2011-1-CN-06 Novel Interferon-Lambda4 (IFNL4) Protein, Related Nucleic Acid Molecules, and Uses Thereof CN National Stage 201380028364.4 Issued
NCI E-217-2011-1-CH-13 Novel Interferon-Lambda4 (IFNL4) Protein, Related Nucleic Acid Molecules, and Uses Thereof CH EP 13712655.3 Issued
NCI E-217-2011-1-GB-16 Novel Interferon-Lambda4 (IFNL4) Protein, Related Nucleic Acid Molecules, and Uses Thereof GB EP 13712655.3 Issued
NCI E-217-2011-1-EP-07 Novel Interferon-Lambda4 (IFNL4) Protein, Related Nucleic Acid Molecules, and Uses Thereof EP National Stage 13712655.3 Issued
NCI E-217-2011-1-FR-15 Novel Interferon-Lambda4 (IFNL4) Protein, Related Nucleic Acid Molecules, and Uses Thereof FR EP 13712655.3 Issued
NCI E-217-2011-1-DE-14 Novel Interferon-Lambda4 (IFNL4) Protein, Related Nucleic Acid Molecules, and Uses Thereof DE EP 13712655.3 Issued
NCI E-217-2011-1-AU-03 Novel Interferon-Lambda4 (IFNL4) Protein, Related Nucleic Acid Molecules, and Uses Thereof AU National Stage 2013240301 Issued
NCI E-019-2012-0-FR-07 Soluble Engineered Monomeric FC FR EP 13713301.3 Issued
NCI E-019-2012-0-DE-06 Soluble Engineered Monomeric FC DE EP 13713301.3 Issued
NCI E-019-2012-0-GB-08 Soluble Engineered Monomeric FC GB EP 13713301.3 Issued
NCI E-019-2012-0-EP-03 Soluble Engineered Monomeric FC EP National Stage 13713301.3 Issued
NCI E-217-2011-1-JP-09 Novel Interferon-Lambda4 (IFNL4) Protein, Related Nucleic Acid Molecules, and Uses Thereof JP National Stage 2015-503310 Issued
NCI E-289-2011-0-US-03 YEAST-MUC1 IMMUNOTHERAPY COMPOSITIONS AND USES THEREOF US National Stage 13/803,757 9533031 Issued PDF
NCI E-056-2011-0-US-03 Yeast-Brachyury Immunotherapeutic Compositions US National Stage 13/803,719 9198941 Issued PDF
NCI E-217-2011-1-PCT-02 Novel Interferon-Lambda4 (IFNL4) Protein, Related Nucleic Acid Molecules, and Uses Thereof PCT PCT PCT/US2013/031624 Expired
NCI E-019-2012-0-PCT-02 Soluble Engineered Monomeric FC PCT PCT PCT/US13/31593 Expired
NIAID E-039-1999-0-US-14 A Novel Chimeric Protein for Prevention and Treatment of HIV Infection US DIV 13/831,464 Abandoned
NCI E-217-2011-1-BR-04 Novel Interferon-Lambda4 (IFNL4) Protein, Related Nucleic Acid Molecules, and Uses Thereof BR National Stage BR112014023642-9 Abandoned
NCI E-217-2011-1-IN-08 Novel Interferon-LambdA4 (IFNL4) Protein, Related Nucleic Acid Molecules, and Uses Thereof IN National Stage 8806/DELNP/2014 Abandoned
NIAAA E-316-2013-0-US-01 Process for producing (R)-3-Hydroxybutyl (R)-3-Hydroxybutyrate US 61/783,167 Abandoned
NHGRI E-060-2013-0-US-01 Compositions and Methods for Predicting Age of Onset of A Lysosomal Storage Disease or a Disease Associated with a Lysosomal Defect US 61/781,807 Abandoned
NHGRI E-056-2013-0-US-01 Biomarker For Hyposialylation Disorders US 61/785,094 Abandoned
NCI E-094-2013-0-US-01 Peptide and Peptide Mimetic Binding Antagonists of Polo-like Kinase 1 Polo Box Domain and Methods of Use US 61/784,971 Abandoned
NIMH E-053-2013-0-US-01 A Diagnostic Kit For Assessing Exposure Or Infection By The Koala Family Of Gammaretroviruses US 61/784,763 Abandoned
NIDCD E-247-2011-0-US-01 SYSTEMS AND METHODS FOR BLEACHING/BLINKING ASSISTED LOCALIZATION MICROSCOPY FOR SUPERRESOLUTION IMAGING USING STANDARD FLUORESCENT MOLECULES US 61/784,266 Abandoned
NCATS E-299-2012-0-US-01 Pyrazolo[1,5-a]pyrimidine Derivatives As Selective Inhibitors Of ALK Kinases For Inhibition Of The Bone Morphogenetic Proteins (BMP) Signaling Pathway US 61/783,695 Abandoned
NIAID E-112-2013-0-US-01 Use of Arsenical Compounds to Treat Inflammatory Diseases US 61/784,138 Abandoned
NHLBI E-027-2013-0-US-01 Devices And Methods for Treating Functional Triscupid Valve Regurgitation US 61/785,652 Abandoned
NCI E-055-2011-0-IT-11 BRACHYURY PROTEIN, NON-POXVIRUS NON-YEAST VECTORS ENCODING BRACHYURY PROTEIN, AND THEIR USE IT EP 13773456.2 Issued
NCI E-055-2011-0-FR-09 BRACHYURY PROTEIN, NON-POXVIRUS NON-YEAST VECTORS ENCODING BRACHYURY PROTEIN, AND THEIR USE FR EP 13773456.2 Issued
NCI E-055-2011-0-DE-07 BRACHYURY PROTEIN, NON-POXVIRUS NON-YEAST VECTORS ENCODING BRACHYURY PROTEIN, AND THEIR USE DE EP 13773456.2 Issued
NCI E-055-2011-0-CH-06 BRACHYURY PROTEIN, NON-POXVIRUS NON-YEAST VECTORS ENCODING BRACHYURY PROTEIN, AND THEIR USE CH EP 13773456.2 Issued
NCI E-055-2011-0-GB-10 BRACHYURY PROTEIN, NON-POXVIRUS NON-YEAST VECTORS ENCODING BRACHYURY PROTEIN, AND THEIR USE GB EP 13773456.2 Issued